Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

23andme logo

23andMe targets $150 million for drug development

July 8, 2015 Research and Development 23andME, DNA, DNA testing, genetics, venture capital

The genetic testing firm 23andMe is seeking to raise $150 million in order to move into its own drug development …
News
bayer_alexander_moscho_thumbnail

European medicines group appoints Bayer’s Alex Moscho as new chair

July 7, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Alexander Moscho, EMG, European Medicines Group

Leading UK industry group the European Medicines Group (EMG) has elected Dr Alexander Moscho, the managing director of Bayer UK …
Appointment
Bayer's Alexander Moscho

Working Life: Bayer UK & Ireland’s chief executive Alexander Moscho

July 6, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Alexander Moscho, Bayer

How did you find your way into your current role?I think it started when I was young and I was …
Feature

Adam Zaeske appointed as managing director of Takeda UK and Ireland

July 6, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adam Zaeske, Takeda

Japanese pharma firm Takeda has appointed Adam Zaeske as managing director of Takeda UK and Ireland.Zaeske has been with Takeda …
Appointment
Vertex logo

Vertex’s cystic fibrosis drug gets FDA approval

July 3, 2015 Research and Development, Sales and Marketing FDA, Orkambi, Vertex, cystic fibrosis, gene therapy

Vertex Pharmaceuticals cystic-fibrosis drug Orkambi, which could treat as many as 8,500 patients in the US, has been approved by …
News
Drug R&D

Pharma outsourcing: CROs, CMOs and external collaboration

July 2, 2015 Manufacturing and Production, Research and Development CMOs, R&D, clinical trials, collaboration, cros, outsourcing

Thirty years ago pharma companies seemed to use external contractors as a sort of fire brigade, to be called in …
Feature
dr_goddard

Mission Therapeutics appoints Dr Colin Goddard to its board of directors

July 2, 2015 Research and Development Colin Goddard, Mission Therapeutics, appointments

MISSION Therapeutics, a drug discovery and development company today has appointed Dr Colin Goddard, former chief executive of OSI Pharmaceuticals, …
Appointment
Professor Dame Sally Davies

Pfizer partners with NIHR to boosts UK R&D

July 1, 2015 Research and Development Manchester, NIHR, Pfizer, R&D, Sally Davies

Pfizer has signed an agreement with the National Institute for Health Research Clinical Research Network to conduct more clinical research …
News

Boehringer and Vitae Pharma drug fails in mid-stage trial

July 1, 2015 Research and Development BI, Boehringer, Boehringer Ingelheim, Vitae Pharmaceuticals, diabetes, type 2 diabetes

A pipeline diabetes drug co-developed by Vitae Pharma and German giants Boehringer Ingelheim has failed to show benefits in a …
News
image

Celgene enters 10-year $1 billion pact with Juno

June 30, 2015 Research and Development, Sales and Marketing CAR-T, Celgene, Chimeric Antigen Receptor Technology, Juno, T Cell Receptor, TCR, brett wells

Celgene has invested $1 billion into Juno Therapeutics as part of a 10-year partnership aiming to study cures for cancer …
News
peter_henshaw

The Partners hires creative director from InVentive

June 30, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Novo Nordisk, The International Aids Society, The partners, inventive, peter henshaw

Brand consultancy The Partners has appointed creative director Peter Henshaw to lead its creative offerings for the agency’s health team.  …
Appointment
Lilly image

Lilly and Immunocore collaborate on melanoma

June 29, 2015 Research and Development, Sales and Marketing LY2157299, LY2801653, brett wells, immunocore, lilly

Eli Lilly is teaming up again with UK biotech Immunocore in order to work together on immunotherapy-based clinical trials. Specifically …
News
New planned building for genomics firm Illumina in Cambridge image

UK pharma’s ‘Golden Triangle’ faces competition from new challengers

June 29, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BioGateway, Cambridge, London, Oxford

The UK’s medical and scientific base is regarded as one of the world’s best.
Feature
Boehringer image

Boehringer scores trial success for Pradaxa antidote

June 29, 2015 Research and Development, Sales and Marketing Boehringer, Pradaxa, idarucizumab

Bosses at Boehringer Ingelheim say the latest results of a study of idarucizumab, and antidote for its blockbuster blood-thinner Pradaxa, …
News
charles_woler

Synexus announces new board

June 29, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Synexus, woler

Following a management buyout Synexus has confirmed who its new board members are to steer the UK recruitment and clinical …
Appointment
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026